carmustine has been researched along with metallothionein in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Apostoli, P; Beggiolin, G; Beretta, GL; Carenini, N; Colangelo, D; Corna, E; Dal Bo, L; Gatti, L; Leone, R; Lombardi, L; Perego, P; Piazzoni, L; Righetti, SC; Tinelli, S; Zunino, F | 1 |
| Helal, GK; Helal, OK | 1 |
| Bacolod, MD; Bigner, DD; Bullock, NS; Colvin, M; Fehdrau, R; Friedman, HS; Johnson, SP | 1 |
3 other study(ies) available for carmustine and metallothionein
| Article | Year |
|---|---|
Development of resistance to a trinuclear platinum complex in ovarian carcinoma cells.
Topics: Antineoplastic Agents; Apoptosis; Base Pair Mismatch; Carmustine; Checkpoint Kinase 1; Cisplatin; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; DNA Adducts; DNA Damage; DNA Repair; DNA, Neoplasm; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; G1 Phase; Glutathione; Humans; Melphalan; Metallothionein; Organoplatinum Compounds; Ovarian Neoplasms; Paclitaxel; Protein Kinases; Tumor Cells, Cultured | 2003 |
Metallothionein attenuates carmustine-induced oxidative stress and protects against pulmonary fibrosis in rats.
Topics: Animals; Antineoplastic Agents, Alkylating; Carmustine; Collagen; Glutathione; Glutathione Reductase; Hydroxyproline; Injections, Intraperitoneal; Lung; Male; Metallothionein; Oxidative Stress; Pulmonary Fibrosis; Random Allocation; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha | 2009 |
BCNU-sequestration by metallothioneins may contribute to resistance in a medulloblastoma cell line.
Topics: Carmustine; Cerebellar Neoplasms; Drug Resistance, Neoplasm; Humans; Medulloblastoma; Metallothionein; Tumor Cells, Cultured | 2009 |